Diagnósticos da América S.A. (BVMF: DASA3)
Brazil
· Delayed Price · Currency is BRL 3.030
0.00 (0.00%)
Sep 11, 2024, 4:52 PM GMT-3
Diagnósticos da América Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 14,771 | 14,252 | 13,129 | 10,419 | 7,039 | 4,365 | Upgrade
|
| Revenue Growth (YoY) | 6.50% | 8.56% | 26.01% | 48.01% | 61.28% | 10.96% | Upgrade
|
| Cost of Revenue | 10,814 | 10,365 | 9,330 | 7,302 | 5,284 | 2,818 | Upgrade
|
| Gross Profit | 3,957 | 3,887 | 3,798 | 3,117 | 1,756 | 1,546 | Upgrade
|
| Selling, General & Admin | 2,961 | 2,975 | 2,864 | 3,066 | 1,635 | 1,148 | Upgrade
|
| Other Operating Expenses | -2.22 | -1.62 | -82.44 | -37.94 | -45.39 | 4.41 | Upgrade
|
| Operating Expenses | 2,986 | 2,974 | 2,782 | 3,028 | 1,589 | 1,152 | Upgrade
|
| Operating Income | 970.95 | 913.32 | 1,017 | 88.52 | 166.55 | 394.22 | Upgrade
|
| Interest Expense | -1,710 | -1,791 | -1,678 | -669.19 | -562.3 | -273.38 | Upgrade
|
| Interest & Investment Income | 165.31 | 262.67 | 289.63 | 206.45 | 176.31 | 62.77 | Upgrade
|
| Other Non Operating Income (Expenses) | -250.52 | -380.82 | -207.24 | - | - | -49.05 | Upgrade
|
| EBT Excluding Unusual Items | -824.4 | -995.95 | -578.8 | -374.23 | -219.44 | 134.56 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 4.06 | Upgrade
|
| Pretax Income | -824.48 | -995.95 | -578.8 | -374.23 | -219.44 | 138.62 | Upgrade
|
| Income Tax Expense | 130.15 | 133.82 | -191.03 | -157.29 | -71.7 | 8.4 | Upgrade
|
| Earnings From Continuing Operations | -954.62 | -1,130 | -387.77 | -216.94 | -147.74 | 130.22 | Upgrade
|
| Earnings From Discontinued Operations | -26.58 | -28.23 | - | - | - | - | Upgrade
|
| Net Income to Company | -981.2 | -1,158 | -387.77 | -216.94 | -147.74 | 130.22 | Upgrade
|
| Minority Interest in Earnings | -17.25 | -8.02 | 0.84 | -9.63 | -3.06 | -5.45 | Upgrade
|
| Net Income | -998.44 | -1,166 | -386.92 | -226.57 | -150.8 | 124.78 | Upgrade
|
| Net Income to Common | -998.44 | -1,166 | -386.92 | -226.57 | -150.8 | 124.78 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -32.33% | Upgrade
|
| Shares Outstanding (Basic) | 747 | 747 | 558 | 585 | 481 | 315 | Upgrade
|
| Shares Outstanding (Diluted) | 747 | 747 | 558 | 585 | 481 | 335 | Upgrade
|
| Shares Change (YoY) | 14.35% | 33.84% | -4.63% | 21.75% | 43.56% | 0.94% | Upgrade
|
| EPS (Basic) | -1.34 | -1.56 | -0.69 | -0.39 | -0.31 | 0.40 | Upgrade
|
| EPS (Diluted) | -1.34 | -1.56 | -0.69 | -0.39 | -0.31 | 0.37 | Upgrade
|
| EPS Growth | - | - | - | - | - | -32.96% | Upgrade
|
| Free Cash Flow | -1,021 | -1,438 | -709.95 | 650.32 | 212.84 | 289.21 | Upgrade
|
| Free Cash Flow Per Share | -1.37 | -1.93 | -1.27 | 1.11 | 0.44 | 0.86 | Upgrade
|
| Dividend Per Share | - | - | - | 0.301 | 0.285 | 0.563 | Upgrade
|
| Dividend Growth | - | - | - | 5.55% | -49.35% | 0.39% | Upgrade
|
| Gross Margin | 26.79% | 27.27% | 28.93% | 29.92% | 24.94% | 35.43% | Upgrade
|
| Operating Margin | 6.57% | 6.41% | 7.74% | 0.85% | 2.37% | 9.03% | Upgrade
|
| Profit Margin | -6.76% | -8.18% | -2.95% | -2.17% | -2.14% | 2.86% | Upgrade
|
| Free Cash Flow Margin | -6.91% | -10.09% | -5.41% | 6.24% | 3.02% | 6.63% | Upgrade
|
| EBITDA | 1,605 | 1,528 | 1,589 | 1,018 | 932.14 | 657.46 | Upgrade
|
| EBITDA Margin | 10.87% | 10.72% | 12.10% | 9.77% | 13.24% | 15.06% | Upgrade
|
| D&A For EBITDA | 634.54 | 614.92 | 571.96 | 929.76 | 765.59 | 263.24 | Upgrade
|
| EBIT | 970.95 | 913.32 | 1,017 | 88.52 | 166.55 | 394.22 | Upgrade
|
| EBIT Margin | 6.57% | 6.41% | 7.74% | 0.85% | 2.37% | 9.03% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 6.06% | Upgrade
|
| Advertising Expenses | - | 86.01 | 101.35 | - | - | 45.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.